SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-323245
Filing Date
2013-08-07
Accepted
2013-08-07 10:10:56
Documents
10
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d545902d10q.htm 10-Q 496156
2 EX-31.1 d545902dex311.htm EX-31.1 6130
3 EX-31.2 d545902dex312.htm EX-31.2 6119
4 EX-32.1 d545902dex321.htm EX-32.1 7399
  Complete submission text file 0001193125-13-323245.txt   6932086

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rgen-20130630.xml EX-101.INS 711517
6 XBRL TAXONOMY EXTENSION SCHEMA rgen-20130630.xsd EX-101.SCH 40860
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgen-20130630_cal.xml EX-101.CAL 67234
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgen-20130630_def.xml EX-101.DEF 283889
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgen-20130630_lab.xml EX-101.LAB 380667
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgen-20130630_pre.xml EX-101.PRE 332197
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-14656 | Film No.: 131016114
SIC: 2836 Biological Products, (No Diagnostic Substances)